Brett Sandercock

2013

In 2013, Brett Sandercock earned a total compensation of $2.5M as Chief financial officer at ResMed, a 9% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$448,335
Salary$505,266
Stock Awards$1,500,008
Other$52,314
Total$2,505,923

Sandercock received $1.5M in stock awards, accounting for 60% of the total pay in 2013.

Sandercock also received $448.3K in non-equity incentive plan, $505.3K in salary and $52.3K in other compensation.

Rankings

In 2013, Brett Sandercock's compensation ranked 3,116th out of 12,286 executives tracked by ExecPay. In other words, Sandercock earned more than 74.6% of executives.

ClassificationRankingPercentile
All
3,116
out of 12,286
75th
Division
Manufacturing
1,054
out of 4,614
77th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
138
out of 677
80th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
80
out of 416
81st
Industry
Surgical and Medical Instruments and Apparatus
43
out of 259
83rd
Source: SEC filing on October 1, 2015.

Sandercock's colleagues

We found seven more compensation records of executives who worked with Brett Sandercock at ResMed in 2013.

2013

Peter Farrell

ResMed

Chairman

2013

Michael Farrell

ResMed

Chief Executive Officer

2013

Rob Douglas

ResMed

Chief Operating Officer

2013

Robert Douglas

ResMed

Chief Operating Officer

2013

Jim Hollingshead

ResMed

President - Americas

2013

James Hollingshead

ResMed

President - Americas

2013

David Pendarvis

ResMed

Chief Administrative Officer

News

You may also like